{"name":"Micelle BioPharma Inc","slug":"micelle-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SC411","genericName":"SC411","slug":"sc411","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"SC411","genericName":"SC411","slug":"sc411","phase":"phase_3","mechanism":"SC411 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxObEctV2NQUndtcVFyanZEMXlzeEw4UC1sbUVkNm51TWs5RFFjeEFyOC1rYU5WQUFXQlJyT3FTUnJsbWJmUklmZVpOMlJuRzhIRE5DWUpuXzZERUJQVWxFSzNRVnl0RmVta1c5VGZ0VUxpU3FnckJCaUd3MWVXdmM1WFBnM2h1VHNIblhRMFduMmJKcGsxcTkwMzVxMWUxVHM?oc=5","date":"2026-01-06","type":"pipeline","source":"Fierce Biotech","summary":"Gilead garners lipid package for cancer asset in $300M research pact - Fierce Biotech","headline":"Gilead garners lipid package for cancer asset in $300M research pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9Wa0hFcjVpSUhtNU5zVldybjRXNnlmV2FFeGU1UVlVUHJpNDA5OURXU1UzcW1MWGxndGkwcHVGdWxDTFpNQlR2S2xXcm45Tk1BX0Fsa2lxUV9TTE03MWMtdDNZdzFHN0RJcmpLeHNZUUU?oc=5","date":"2025-06-02","type":"regulatory","source":"Wiley Online Library","summary":"Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape - Wiley Online Library","headline":"Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQTUtseTRwZzRRNXpjRmJITFZTTHJoWEk1S1dYTlp2T1B5Tmw3QnhmVFlNU2ZTOEloVXNUVE9ZcHFpdFZuZThfa1k4WjBjY3FtMXV4R01tWHgwajFTb1haTXphdHpkcVBGLURMWkRxV1ZIdGxINndfVzlaa0pDWWEwVmJoaTdZc0QwUk9TcW01cWszTmJnZ1BHYl9jRkxOczczby1LdzRn?oc=5","date":"2019-08-29","type":"deal","source":"eHealth Magazine","summary":"Drugmaker Strides Pharma acquires manufacturing facility in US - eHealth Magazine","headline":"Drugmaker Strides Pharma acquires manufacturing facility in US","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2019-08-27","type":"regulatory","source":"Moneycontrol.com","summary":"Strides acquires USFDA approved manufacturing facility in US - Moneycontrol.com","headline":"Strides acquires USFDA approved manufacturing facility in US","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNQUFNaEZtc1ZVZ1RmcGNyVFp0NnhHOHo3UHhyV0szdHpjRkNYQi1oRHdXYllic1hkdDZWRUF4NmpIMlNRVXBNU0VpNUdfYXdHRmYxWUlQNWk1ZmJCc0JxMXpTM3dwVnFwSXRlMHlPQmxUUG1jX3JZdXNlTmdhSkI0NkxibUE2SV9LWkVUZnhieDh6Qy10M3A3YjY5aDZZdzQxQ2hBb1ZnTFdMVU5odkhheTc4N05BTVAydG43RA?oc=5","date":"2019-02-04","type":"pipeline","source":"The Palm Beach Post","summary":"Once a high flier, drug company hit hard times - The Palm Beach Post","headline":"Once a high flier, drug company hit hard times","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}